美国 · 通讯社与实时数据 · Bloomberg

Gilead-Backed Aspen Neuroscience Shares Decline 2% After US IPO

来源：Bloomberg · 美国 2 小时前

Aspen Neuroscience Inc., a clinical-stage developer of cell therapies, fell 2% after raising about $140.6 million in a US initial public offering.

在 Bloomberg 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bloomberg.com)

推荐阅读

Xinhua Silk Road : Le 11e Forum mondial sur le culte de la déesse Mazu s'ouvrira à Putian, dans le sud-est de la Chine, le 31 octobre

Associated Press (Business)

Greenland opens new international airport to lure tourists as it eyes future independence

Nebius Group announces date of third quarter 2026 results and conference call

Dow Jones Newswires

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows